Phenotypic variability and its pathological basis in amyotrophic lateral sclerosis

Area of Science:

• Neuroscience
• Neuropathology
• Genetics

Background:

• Amyotrophic lateral sclerosis (ALS) presents with considerable clinicopathological variability.
• While most patients exhibit both upper and lower motor neuron signs, atypical presentations include isolated signs or extra-motor symptoms like cognitive dysfunction and parkinsonism.

Purpose of the Study:

• To explore the clinicopathological variability in ALS.
• To investigate the role of transactivation response DNA-binding protein 43 kDa (TDP-43) pathology and potential region-specific cellular vulnerabilities in ALS pathogenesis.

Main Methods:

• Analysis of clinicopathological features in ALS patients.
• Examination of TDP-43 inclusions and neuronal loss across different CNS regions.
• Correlation of pathological findings with clinical presentation and disease progression patterns.

Main Results:

• TDP-43 cytoplasmic inclusions are a hallmark of ALS, but their presence does not always correlate with neuronal loss.
• Regional differences in TDP-43 accumulation and neuronal loss suggest underlying region-specific cellular vulnerabilities.
• Clinical variability in ALS may stem from multicentric disease onset and region-oriented progression.

Conclusions:

• ALS pathogenesis is complex, involving TDP-43 dysfunction and potentially region-specific vulnerabilities.
• The observed clinicopathological variability highlights diverse disease manifestations and progression patterns in ALS.
• Further research into these variations is essential for a comprehensive understanding of ALS and for developing targeted therapies.